medigraphic.com
SPANISH

Archivos en Medicina Familiar

Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2007, Number 4

<< Back Next >>

Arch Med Fam 2007; 9 (4)

Estudio de utilización de medicamentos: experiencia en un centro de salud en Villa Gobernador Gálvez, Santa Fe (Argentina)

Trezzo JC, Weisburd G
Full text How to cite this article

Language: Spanish
References: 10
Page: 159-163
PDF size: 163.79 Kb.


Key words:

Adverse effects, Pharmacovigilance, Drugs.

ABSTRACT

Objective: To analyze the rational use of drugs at a primary-level health care center in Villa Gobernador Gálvez, Santa Fe, Argentina, during 2005. Design: We conducted a descriptive, cross-sectional, and retrospective study. Materials and Methods: We took into consideration the prescriptions of drugs afforded by physicians at their offices. Drug use of was mainly divided into therapy groups in accordance to the organ upon which they act (ATC). Analysis took place with the indicator known as Defined Daily Doses (DDDs) in response to World Health Organization (WHO) recommendations in drug use studies. Results: We analyzed 1,818 prescriptions derived from 8,016 appointments with physicians. The results showed that the prescribed drugs most frequently widely administered were the following: Enalapril and Hydroclorotiazid; Amoxicillin and Erythromycin, and Ibuprofen and Paracetamol. Conclusions: Analysis of the use of drugs allows to know the health needs of the population and consequently, to plan adequate pharmacologic strategies in response to these requirements.


REFERENCES

  1. Alvarez Luna F. Farmacoepidemiología. Estudios de Utilización de Medicamentos. Parte I: Concepto y metodología. Segim Farmacoter 2004;2(3):129-136.

  2. Rodríguez Betancourt L, García Vigil JL, Giral Barnés C, Hernández Santillán D, Jasso Gutiérrez L. Farmocovigilancia III. La experiencia Internacional. Rev Med IMSS 2005;43(2):131-140. En: Rascón Sabido R, Sabido Siglher AS, Márquez Celedonio FG, Soler Huerta E. Programa de fármacovigilancia en atención primaria: experiencia en una clínica en Veracruz, México. Arch Med Fam 2007; 9 (2): 95-101.

  3. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis and management. Lancet 2000; 356(9237):1212.

  4. Argentina. Ministerio de Salud de la Nación. Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT). En: http://www.anmat.gov.ar/institucional/institucional,htm.

  5. Arnau JM, Vallano A. Estudios de Utilización de Medicamentos. Medicamentos y Salud. 2000; 2: 72-77.

  6. The WHO Collaborating Centre for Drug Statistics Methodology. URL disponible en: http://www.whocc.no/atcddd/.

  7. Remediar: La Hipertensión Arterial y el uso de drogas antihipertensivas.- Atención Primaria de la Salud. Boletín PROAPS REMEDIAR. 2004;2 (13): 10-13.

  8. Organización Mundial de la Salud. Perspectivas políticas sobre medicamentos de la OMS. Promoción del uso de medicamentos: componentes centrales. Ginebra. 2002.

  9. Botting R. Antipyrectic therapy. Front Biosci 2004; 9:956-66.

  10. Lesko SM. The safety of ibuprofen suspension in children. Int J Clin Pract 2003; (Suppl) 5: 50-3.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Med Fam. 2007;9